Christopher Y. Chai, Chief Financial Officer at MAP Pharmaceuticals, Inc. (MAPP), sold 16,000 shares at $16.47 ($266K) on 2010-03-24, disclosed to the SEC on 2010-03-25.
Scheduled sale ($266k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 8,000 | $134K | 50.4% |
| 2 | $16.47 | 8,000 | $132K | 49.6% |
| Total | $16.59 avg | 16,000 | $266K | 100% |
| Filing → |
| PRNB | SELL | 2020-02-20 | $818K | — | Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-09-22 | $225K | — | Filing → |